Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer’s disease

BACKGROUND: To sustain the effect of rivastigmine, a hydrophilic cholinesterase inhibitor, nanobased formulations were prepared. The efficacy of the prepared rivastigmine liposomes (RLs) in comparison to rivastigmine solution (RS) was assessed in an aluminium chloride (AlCl(3))-induced Alzheimer’s m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Manal Fouad, ElMeshad, Aliaa Nabil, Salem, Neveen Abdel-Hameed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558309/
https://www.ncbi.nlm.nih.gov/pubmed/23378761
http://dx.doi.org/10.2147/IJN.S39232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558309/
https://www.ncbi.nlm.nih.gov/pubmed/23378761
http://dx.doi.org/10.2147/IJN.S39232

Ejemplares similares